CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...